Protein clue could unlock new autoimmune treatments

NCT ID NCT04978948

Recruiting now Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is measuring a protein called STIM1 on the surface of immune cells in 670 people with various autoimmune diseases. The goal is to find which diseases have high levels of this protein, which could help researchers develop new antibody-based treatments. Participants provide blood samples, and no experimental treatment is given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify which autoimmune diseases have high STIM1 levels, paving the way for developing new antibody treatments.
What could go wrong: This is an observational study, not a treatment trial. It only measures a protein; it does not test any therapy. Results may not lead to actual treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOIMMUNE DISEASES

Contacts and locations

Locations

CHRU de Brest - Service de rhumatologie
RECRUITING

Brest, Brest, 29200, France
CHU de Martinique
RECRUITING

Fort-de-France, Martinique, 97261, France
Centre Hospitalier de Quimper
RECRUITING

Quimper, Brittany Region, 29000, France
Centre Hospitalier des Pays de Morlaix
RECRUITING

Morlaix, Brittany Region, 29672, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.